We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current B1SX34 market cap is 563.93B. The company's latest EPS is USD 1.0717 and P/E is 70.61.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.39B | 3.6B | 3.64B | 3.73B | 3.86B |
| Operating Income | 551M | 515M | 736M | 541M | 673M |
| Net Income | 300M | 261M | 504M | 505M | 495M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.77B | 10.01B | 11.89B | 12.68B | 14.35B |
| Operating Income | 1.52B | -79M | 984M | 1.67B | 2.34B |
| Net Income | 4.7B | -115M | 985M | 642M | 1.57B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.89B | 33.6B | 34.04B | 35.14B | 36.67B |
| Total Liabilities | 14.78B | 15.12B | 14.91B | 15.61B | 16.5B |
| Total Equity | 18.11B | 18.49B | 19.13B | 19.53B | 20.17B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.57B | 30.78B | 32.23B | 32.47B | 35.14B |
| Total Liabilities | 16.69B | 15.45B | 15.61B | 14.9B | 15.61B |
| Total Equity | 13.88B | 15.33B | 16.62B | 17.57B | 19.53B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 190M | 848M | 1.55B | 2.5B | 164M |
| Investing | -484M | -1.32B | -1.52B | -2.57B | -285M |
| Financing | -69M | -26M | -10M | 5M | 1.57B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.84B | 1.51B | 1.87B | 1.53B | 2.5B |
| Investing | -5.04B | -411M | -1.6B | -2.01B | -2.57B |
| Financing | 2.97B | 293M | -95M | -548M | 5M |
| Market Cap | 563.93B |
| Price to Earnings Ratio | 70.61 |
| Price to Sales Ratio | 7.72 |
| Price to Cash Ratio | 128.15 |
| Price to Book Ratio | 5.68 |
| Dividend Yield | - |
| Shares Outstanding | 1.46B |
| Average Volume (1 week) | 3 |
| Average Volume (1 Month) | 9 |
| 52 Week Change | 44.08% |
| 52 Week High | 384.94 |
| 52 Week Low | 242.62 |
| Spread (Intraday) | 4.94 (1.26%) |
| Company Name | Boston Scientific Corp. |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bostonscientific.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
